Invention Grant
- Patent Title: Composition for inhalation
-
Application No.: US15427425Application Date: 2017-02-08
-
Publication No.: US10166247B2Publication Date: 2019-01-01
- Inventor: Nayna Govind , Maria Marlow
- Applicant: AstraZeneca AB
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agency: Morgan, Lewis & Bockius LLP
- Priority: SE0200312 20020201
- Main IPC: A61K31/58
- IPC: A61K31/58 ; A61K47/32 ; A61K47/34 ; A61K9/00 ; A61K31/167 ; A61K31/573 ; A61K31/194
Abstract:
The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
Public/Granted literature
- US20170368078A1 Composition for Inhalation Public/Granted day:2017-12-28
Information query
